#drug development
7 stories
Indian Pharma Risk Aversion
Indian pharma leaders say risk aversion blocks innovation, urging tech adoption for faster drug development.
The Economic Times · 1m
Isomorphic Labs Targets $40B Valuation
Isomorphic Labs, DeepMind's AI drug discovery spinout, aims for $40 billion valuation after May's $2.1 billion funding round.
Dealroom · 1m
U.S. signals openness to Chinese drug deals
American regulators may allow pharmaceutical licensing with China while restricting AI and semiconductors.
CNBC · 1m
What We Tell Our Kids About AI
Parents in medicine see real breakthroughs alongside genuine risks, and think kids deserve to hear both.
TIME · 2m
Indian pharma company patents insulin eye drops
ENTOD Pharmaceuticals secures patent for a novel topical insulin treatment for eye disease, marking a shift toward original drug innovation in India.
The Economic Times · 1m
Alzheimer's research is finally making real progress
After decades of stalled research, scientists now have new drugs and multiple treatment approaches that offer hope for slowing cognitive decline.
Vox · 3m
Anthropic loosens Fable 5's biology safeguards
The AI company reduced false positives by 85% while still blocking dual-use research that could enable biological weapons.
Anthropic · 2m · 7 views